186 related articles for article (PubMed ID: 38225245)
1. Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis.
Drexhage LZ; Zhang S; Dupont M; Ragaller F; Sjule E; Cabezas-Caballero J; Deimel LP; Robertson H; Russell RA; Dushek O; Sezgin E; Karaji N; Sattentau QJ
Nat Commun; 2024 Jan; 15(1):541. PubMed ID: 38225245
[TBL] [Abstract][Full Text] [Related]
2. Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.
Sriranganathan S; Tutunea-Fatan E; Abbasi A; Gunaratnam L
Mol Cell Biochem; 2021 Feb; 476(2):1093-1108. PubMed ID: 33211259
[TBL] [Abstract][Full Text] [Related]
3. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
Nishi C; Yanagihashi Y; Segawa K; Nagata S
J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.
Ramachandran RP; Spiegel C; Keren Y; Danieli T; Melamed-Book N; Pal RR; Zlotkin-Rivkin E; Rosenshine I; Aroeti B
mBio; 2020 Sep; 11(5):. PubMed ID: 32934081
[TBL] [Abstract][Full Text] [Related]
5. ADAM10-Interacting Tetraspanins Tspan5 and Tspan17 Regulate VE-Cadherin Expression and Promote T Lymphocyte Transmigration.
Reyat JS; Chimen M; Noy PJ; Szyroka J; Rainger GE; Tomlinson MG
J Immunol; 2017 Jul; 199(2):666-676. PubMed ID: 28600292
[TBL] [Abstract][Full Text] [Related]
6. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
[TBL] [Abstract][Full Text] [Related]
7. Klebsiella pneumoniae infection of murine neutrophils impairs their efferocytic clearance by modulating cell death machinery.
Jondle CN; Gupta K; Mishra BB; Sharma J
PLoS Pathog; 2018 Oct; 14(10):e1007338. PubMed ID: 30273394
[TBL] [Abstract][Full Text] [Related]
8. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
[TBL] [Abstract][Full Text] [Related]
9. The plasma membrane: Penultimate regulator of ADAM sheddase function.
Reiss K; Bhakdi S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2082-2087. PubMed ID: 28624437
[TBL] [Abstract][Full Text] [Related]
10. Increased ADAM10 expression in patients with immune thrombocytopenia.
Qiao J; Luo Q; Liu N; Wei G; Wu X; Lu J; Tang K; Wu Y; Zi J; Li X; Liu Y; Ju W; Qi K; Yan Z; Li Z; Zeng L; Xu K
Int Immunopharmacol; 2018 Feb; 55():63-68. PubMed ID: 29223855
[TBL] [Abstract][Full Text] [Related]
11. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
Ebsen H; Schröder A; Kabelitz D; Janssen O
PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD93 is an apoptotic cell opsonin recognized by α
Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B
Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676
[TBL] [Abstract][Full Text] [Related]
13. Redistribution of the glycocalyx exposes phagocytic determinants on apoptotic cells.
Le T; Ferling I; Qiu L; Nabaile C; Assunção L; Roskelley CD; Grinstein S; Freeman SA
Dev Cell; 2024 Apr; 59(7):853-868.e7. PubMed ID: 38359833
[TBL] [Abstract][Full Text] [Related]
14. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
[TBL] [Abstract][Full Text] [Related]
15. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
[TBL] [Abstract][Full Text] [Related]
16. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
Hitschler L; Lang T
J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Efferocytic Receptor Dynamics and Synapse Formation in a Frustrated Efferocytosis Model.
Dickson BH; Heit B
Methods Mol Biol; 2023; 2692():61-77. PubMed ID: 37365461
[TBL] [Abstract][Full Text] [Related]
19. Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.
Dempsey PJ
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2228-2239. PubMed ID: 28739265
[TBL] [Abstract][Full Text] [Related]
20. The Tim gene family in efferocytosis.
Kim D; Lee SA; Moon H; Kim K; Park D
Genes Genomics; 2020 Sep; 42(9):979-986. PubMed ID: 32648232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
